IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Change in Accrued Expenses (2018 - 2026)

Updated

Analysis

IRulya Therapeutics (IRLA) Change in Accrued Expenses (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.41 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 983.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 756.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -7.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.93 Mn
Mar 31, 2026 -7.16 Mn
Dec 31, 2025 5.30 Mn
Sep 30, 2025 -631,000.00
Jun 30, 2025 204,000.00
Mar 31, 2025 899,000.00
Dec 31, 2024 535,000.00
Sep 30, 2024 819,000.00
Jun 30, 2024 94,000.00
Mar 31, 2024 -381,000.00
Dec 31, 2023 -1.40 Mn
Sep 30, 2023 243,000.00
Jun 30, 2023 25,000.00
Mar 31, 2023 -844,000.00
Dec 31, 2022 -1.36 Mn
Sep 30, 2022 -290,000.00
Jun 30, 2022 -2.12 Mn
Mar 31, 2022 -2.89 Mn
Dec 31, 2021 -1.97 Mn
Sep 30, 2021 -107,000.00
API Access

IRulya Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IRLA&period=max&api_key=YOUR_API_KEY